US President Donald Trump’s decree in reducing medical prices will not have significant conclusions. In this regard, by referring to experts, reporting the American portal APPLICATIONS.
According to analysts, Trump’s drug decree is extremely uncertain in nature. The deadline for implementation is also uncertain. Apparently, the president is trying to scare the drug producers only, then he does not clearly understand what will happen later.
In addition, experts say that Trump’s decree is not legally perfect and will probably challenge the court.
May 12 Trump announcedIt plans to reduce drug prices in the country by 59% or more. According to him, the decree aims to eliminate unjustly high drug prices in the United States compared to other states.
May 1, US Chamber of Commerce President Suzanne Clark I directed A letter from Donald Trump, the President of the White House, to urgently cancel the import fee to avoid stagnation.
Previously White House criticized Amazon plans to show the effect of tasks on the price of goods.
What are you thinking?
Source: Gazeta
Ben Stock is a business analyst and writer for “Social Bites”. He offers insightful articles on the latest business news and developments, providing readers with a comprehensive understanding of the business world.